Globe Life Inc
XMUN:TMJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Globe Life Inc
XMUN:TMJ
|
US |
|
Freshpet Inc
NASDAQ:FRPT
|
US |
|
Koppers Holdings Inc
NYSE:KOP
|
US |
|
C
|
Cleveland-Cliffs Inc
F:CVA
|
US |
|
Bank Rakyat Indonesia (Persero) Tbk PT
OTC:BKRKF
|
ID |
|
C
|
CapitaLand Integrated Commercial Trust
DUS:M3T
|
SG |
|
Dutch Bros Inc
NYSE:BROS
|
US |
|
A
|
Akamai Technologies Inc
F:AK3
|
US |
|
ORIX Corp
TSE:8591
|
JP |
|
M
|
Manulife Financial Corp
XPHS:MFC
|
CA |
|
Daito Trust Construction Co Ltd
OTC:DIFTY
|
JP |
Globe Life Inc
Globe Life is an insurance holding company that sells life insurance and supplemental health insurance to individual households in the United States. Its products are designed to pay cash benefits to families when the insured dies or when covered health events happen, and some policies also help with everyday medical or accident-related expenses. It sells mainly through well-known insurance subsidiaries such as American Income Life, Liberty National, and United American. The company makes money by collecting premiums from policyholders and investing the float from those premiums until claims are paid. Its main customers are working families, middle-income households, and older consumers who want simple, affordable coverage rather than large, complex insurance packages. Globe Life also works with agents and direct-to-consumer channels, which lets it reach customers through both personal sales and direct marketing. What sets Globe Life apart is its focus on small, easy-to-understand policies that people can buy without going through a traditional employer benefits plan. That puts it in a different part of the insurance market from companies that mainly sell large group policies or broad financial products. Its business is built around recurring premium income, long-term policy relationships, and careful claims management.
Globe Life is an insurance holding company that sells life insurance and supplemental health insurance to individual households in the United States. Its products are designed to pay cash benefits to families when the insured dies or when covered health events happen, and some policies also help with everyday medical or accident-related expenses. It sells mainly through well-known insurance subsidiaries such as American Income Life, Liberty National, and United American.
The company makes money by collecting premiums from policyholders and investing the float from those premiums until claims are paid. Its main customers are working families, middle-income households, and older consumers who want simple, affordable coverage rather than large, complex insurance packages. Globe Life also works with agents and direct-to-consumer channels, which lets it reach customers through both personal sales and direct marketing.
What sets Globe Life apart is its focus on small, easy-to-understand policies that people can buy without going through a traditional employer benefits plan. That puts it in a different part of the insurance market from companies that mainly sell large group policies or broad financial products. Its business is built around recurring premium income, long-term policy relationships, and careful claims management.
EPS growth: Globe Life reported second-quarter net income of $288 million, or $3.65 per share, up 20% from a year ago, while net operating income was $285 million, or $3.61 per share, up 10%.
Guidance raised: Full-year 2026 net operating EPS guidance moved up to $15.55 to $15.95, driven mainly by stronger life underwriting margins and higher excess investment income.
Life update: Life results were strong, and management expects an unusually high third-quarter margin because of assumption updates, with normalized life margins still expected to run in the 41% to 42% range.
DTC transition: Direct-to-consumer sales were pressured by a shift in online search and advertising toward AI-driven results, but management said it will stay disciplined on spend and protect margins.
Capital returns: Globe Life increased buybacks, repurchased 1.1 million shares for $175 million in the quarter, and now expects full-year share repurchases of $670 million to $700 million.
Bermuda timing: Management said the Bermuda reinsurance structure will not produce a 2026 capital benefit, with some benefit expected in 2027 and more meaningful cash release coming later.
Q2 claims: Health claims ran hotter than expected in the quarter, especially at Evry and Liberty National, but management called those issues temporary and expects moderation later this year.